Mohit Bansal
Stock Analyst at Wells Fargo
(4.68)
# 759
Out of 4,509 analysts
766
Total ratings
59%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by Mohit Bansal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $265 → $285 | $236.97 | +20.27% | 18 | Jul 14, 2026 | |
| AMGN Amgen | Maintained: Hold | $390 | $360.45 | +8.20% | 48 | Jul 13, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $60 | $59.34 | +1.11% | 42 | Jul 13, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,280 | $1,181.87 | +8.30% | 67 | Jul 10, 2026 | |
| ABBV AbbVie | Rated: Buy | $260 → $295 | $248.00 | +18.95% | 41 | Jul 10, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $165 | $131.40 | +25.57% | 63 | Jul 9, 2026 | |
| MRK Merck & Co. | Rated: Buy | $145 → $150 | $124.03 | +20.94% | 52 | Jul 8, 2026 | |
| REGN Regeneron Pharmaceuticals | Rated: Hold | $700 | $663.09 | +5.57% | 66 | Jul 8, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | $70 | $41.50 | +68.67% | 8 | Jul 7, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $550 | $480.25 | +14.52% | 50 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $24.48 | +14.38% | 51 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $76.11 | -1.46% | 26 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $65 | $56.29 | +15.47% | 22 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $15.30 | +96.08% | 11 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $209.03 | +19.60% | 52 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $140 | $90.07 | +55.43% | 10 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $59.20 | +26.69% | 25 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $4.21 | +18.76% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.95 | +118.49% | 1 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $27.59 | +99.35% | 15 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $175 | $174.10 | +0.52% | 31 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $8 | $1.28 | +525.00% | 3 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $67.72 | -30.60% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $74.11 | n/a | 1 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $14 | $33.36 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.00001 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $1.14 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 → $75 | $44.12 | n/a | 3 | Mar 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $33 | $36.15 | n/a | 2 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $1.47 | n/a | 6 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $75 | $6.43 | n/a | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $5 | $0.0003 | n/a | 5 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 → $65 | $40.55 | n/a | 5 | Dec 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $8.5 | $3.70 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $5 | $0.0276 | n/a | 2 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $10.56 | n/a | 1 | Jun 11, 2019 |
Jazz Pharmaceuticals
Jul 14, 2026
Rated: Buy
Price Target: $265 → $285
Current: $236.97
Upside: +20.27%
Amgen
Jul 13, 2026
Maintained: Hold
Price Target: $390
Current: $360.45
Upside: +8.20%
Bristol-Myers Squibb Company
Jul 13, 2026
Maintained: Hold
Price Target: $60
Current: $59.34
Upside: +1.11%
Eli Lilly and Company
Jul 10, 2026
Maintained: Buy
Price Target: $1,280
Current: $1,181.87
Upside: +8.30%
AbbVie
Jul 10, 2026
Rated: Buy
Price Target: $260 → $295
Current: $248.00
Upside: +18.95%
Gilead Sciences
Jul 9, 2026
Maintained: Buy
Price Target: $165
Current: $131.40
Upside: +25.57%
Merck & Co.
Jul 8, 2026
Rated: Buy
Price Target: $145 → $150
Current: $124.03
Upside: +20.94%
Regeneron Pharmaceuticals
Jul 8, 2026
Rated: Hold
Price Target: $700
Current: $663.09
Upside: +5.57%
Vera Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $70
Current: $41.50
Upside: +68.67%
Vertex Pharmaceuticals
Jul 6, 2026
Maintained: Buy
Price Target: $550
Current: $480.25
Upside: +14.52%
Jun 22, 2026
Maintained: Hold
Price Target: $28
Current: $24.48
Upside: +14.38%
Jun 15, 2026
Rated: Hold
Price Target: $75
Current: $76.11
Upside: -1.46%
Jun 11, 2026
Maintained: Buy
Price Target: $50 → $65
Current: $56.29
Upside: +15.47%
Jun 2, 2026
Rated: Buy
Price Target: $30
Current: $15.30
Upside: +96.08%
May 22, 2026
Maintained: Buy
Price Target: $250
Current: $209.03
Upside: +19.60%
May 22, 2026
Maintained: Buy
Price Target: $140 → $140
Current: $90.07
Upside: +55.43%
May 21, 2026
Rated: Buy
Price Target: $75
Current: $59.20
Upside: +26.69%
May 5, 2026
Maintained: Hold
Price Target: $5
Current: $4.21
Upside: +18.76%
Apr 1, 2026
Maintained: Buy
Price Target: $13
Current: $5.95
Upside: +118.49%
Mar 13, 2026
Maintained: Buy
Price Target: $55
Current: $27.59
Upside: +99.35%
Feb 13, 2026
Maintained: Buy
Price Target: $180 → $175
Current: $174.10
Upside: +0.52%
Dec 16, 2025
Maintained: Buy
Price Target: $4 → $8
Current: $1.28
Upside: +525.00%
Aug 12, 2025
Maintained: Buy
Price Target: $47
Current: $67.72
Upside: -30.60%
Jul 2, 2021
Reiterated: Buy
Price Target: $95
Current: $74.11
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $30 → $14
Current: $33.36
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $3
Current: $0.00001
Upside: n/a
Apr 5, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $1.14
Upside: n/a
Mar 26, 2021
Initiated Coverage: Buy
Price Target: $15 → $75
Current: $44.12
Upside: n/a
Mar 24, 2021
Maintained: Buy
Price Target: $20 → $33
Current: $36.15
Upside: n/a
Feb 25, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $1.47
Upside: n/a
Jan 20, 2021
Maintained: Buy
Price Target: $36 → $75
Current: $6.43
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $10 → $5
Current: $0.0003
Upside: n/a
Dec 23, 2020
Maintained: Buy
Price Target: $75 → $65
Current: $40.55
Upside: n/a
Sep 15, 2020
Maintained: Hold
Price Target: $11 → $8.5
Current: $3.70
Upside: n/a
Apr 27, 2020
Maintained: Buy
Price Target: $8 → $5
Current: $0.0276
Upside: n/a
Jun 11, 2019
Initiated Coverage: Buy
Price Target: $21
Current: $10.56
Upside: n/a